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Plasma LDL subtype distribution in patients with or
without coronary stenosis
Yeşim ER ÖZTAŞ1, Cağdaş ÖZDÖL2, Levent KARACA3

Aim: Plasma low density lipoprotein (LDL) had 3 subtypes according to its separation by polyacrylamide gradient gel
electrophoresis. Of these, the small, dense (Sd) LDL particles have been accepted as an emerging cardiovascular risk
factor. This study was conducted to assess the LDL subtypes in a group of patients undergoing coronary angiography.
Materials and methods: The study involved 56 patients—36 of whom had at least 1 vessel stenosed (stenosis group)—
and 20 patients who had no stenosis (non-stenosis group). LDL subtypes were determined according to their migration
pattern after non-denaturing gradient gel electrophoresis. Total cholesterol, LDL and high density lipoprotein (HDL),
and triglyceride levels were also evaluated.
Results: Sd LDL positivity was slightly increased in the stenosis group, but the difference was not significant. Mean HDL
levels were lower in the stenosis group; other lipid parameters were similar between the groups. Patients with Sd LDL
positivity had significantly higher levels of triglyceride (P < 0.005).
Conclusion: In the current study Sd LDL positivity was relatively higher in coronary stenosis patients; however, it is not
statistically significant.
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Koroner arter stenozu olan ve olmayan hastalarda plazma
LDL alt tiplerinin dağılımı
Amaç: Plazma düşük densiteli lipoproteini (LDL), poliakrilamid jel elektroforeziyle 3 alt birime ayrılır. Bunlardan
küçük, yoğun LDL partikülü yeni ortaya çıkan bir kardiyovasküler risk faktörü olarak kabul görmektedir. Bu çalışmada
koroner anjiyografik inceleme yapılan bir grup hastada LDL alt tiplerinin belirlenmesi amaçlanmıştır.
Yöntem ve gereç: Çalışmada en az bir damarında tıkanıklık olan 36 ve tıkanıklığı olmayan 20 hasta yer aldı. LDL alt
grupları denatüran olmayan gradiyent jel elktroforezindeki migrasyon paternine göre belirlendi. Ayrıca total kolesterol,
LDL, yüksek densiteli lipoprotein (HDL) ve trigliserit düzeyleri belirlendi.
Bulgular: Ortalama HDL düzeyleri stenozlu grupta daha düşükken, diğer lipit parametreleri gruplar arasında benzerdi.
Küçük, yoğun LDL pozitifliği stenoz grubunda biraz daha yüksekken, fark anlamlı değildi. Küçük, yoğun LDL pozitifliği
olan hastalarda trigliserit düzeyleri anlamlı olarak yüksektir (P < 0,005).
Sonuç: Bu çalışmada küçük, yoğun LDL pozitifliği koroner stenozlu hastalarda rölatif olarak yüksekse de istatistiksel
anlamlı fark görülmemiştir.
Anahtar sözcükler: Lipoprotein, küçük, yoğun LDL, ateroskleroz, koroner stenoz
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Introduction
Atherosclerosis plays a major role in the
pathology of cardiovascular diseases. Practically all
patients with myocardial infarction, as defined by
electrocardiography and enzymatic changes, have
coronary atherosclerosis. Coronary artery disease
(CAD) has been an important cause of morbidity and
mortality in Turkey for the last 2 decades (1,2)
Elevated serum cholesterol, especially low
density lipoprotein (LDL) cholesterol, is established
as a major risk factor—along with sex, age, family
history, hypertension, smoking, and diabetes—
in the development of CAD (3). In addition to
hypercholesterolemia, hypertriglyceridemia is a risk
parameter for atherosclerosis (4). Discovering novel
diagnostic markers for early detection and follow up
of CAD has been the objective of many studies in this
area (5).
LDL particles heterogeneous in respect to size,
density, and lipid composition have been divided
into 3 subtypes: large, more buoyant LDL particles;
medium LDL particles; and small, dense (Sd LDL)
LDL particles (6). Sd LDL particles have been found
to be atherogenic because of their smaller particle
size, diminished recognition by the LDL receptor,
prolonged residence time in plasma, and lower
resistance to oxidative stress compared to large,
buoyant LDL (7,8). Several studies have reported a
2- to 3-fold increase in coronary heart disease risk
among patients with this Sd LDL subtype (9). A
preponderance of Sd LDL particles has been accepted
as an emerging cardiovascular risk factor by the
National Cholesterol Education Program (NCEP)
Adult Treatment Panel III, USA (10).
A number of methods have been developed to
characterize LDL heterogeneity. Density gradient
ultracentrifugation of plasma or isolated LDL has
been commonly used to separate the LDL particles
according to density (11). An advantage of the
ultracentrifugation technique is the possibility
for compositional studies of LDL subtypes.
Non-denaturing polyacrylamide gradient gel
electrophoresis, on the other hand, separates LDL
according to particle size, is comparably easy to
perform, and has been extensively used in clinical
studies.
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This study aimed to detect LDL subtypes in the
plasmas of patients undergoing coronary angiography
by non-denaturing gradient gel electrophoresis and to
search for an association between Sd LDL positivity
and coronary stenosis.
Materials and methods
Subjects
The study was approved by the institutional review
board and the patients who attended cardiology
clinic consented to a full diagnostic workup. Enrolled
in the study were 56 consecutive patients who had
undergone coronary angiography at the cardiology
laboratory of Ibn-i Sina Hospital, Ankara, Turkey,
during the same month. Patients older than 75 years
and those with severe renal, hepatic, infectious or
malignant disease or any other clinical instability
after angiography were excluded from the study.
Blood samples were drawn after an overnight fast.
After routine tests had been performed, plasmas were
stored at –80 °C for LDL subtype analysis.
Lipid analysis
Total cholesterol (TC), triglyceride (TG), and high
density lipoprotein cholesterol (HDL) levels were
determined on a Technicon Dax-96 autoanalyzer
using enzymatic reagents (Biotrol Diagnostics)
and anti-human β lipoprotein precipitation (Sigma
Diagnostics) (12,13) . LDL cholesterol levels were
estimated for all subjects by using Friedewald’s
formula (14). When TG levels were higher than 400
g/dL, LDL levels were determined by enzymatic assay
(Centronic).
Gradient gel electrophoresis
LDL was separated by gradient gel electrophoresis
with a linear non-denaturing polyacrylamide
gradient of 3% to 7.5%. Gradient gels were cast
using a manual gradient maker (170−9042 Model
475 Gradient Delivery System, Bio-Rad, Richmond,
CA, USA). Just before pouring, freshly prepared
10% (w/v) ammonium persulfate (Merck) was
added to the acrylamide (Sigma) solutions to attain
a polymerization time of 90 min. Poured into each
injector of the gradient maker were: 20 mL of
3% acrylamide solution (acrylamide, 29.25 g/L;
bisacrylamide, 0.75 g/L; Tris, 0.375 mol/L, pH 8.35;
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Temed, 0.6 mL/mL; ammonium persulfate, 1 g/L)
and 20 mL of 7.5% acrylamide solution (acrylamide,
73.125 g/L; bisacrylamide, 1.875 g/L; Tris, 0.375
mol/L, pH 8.35; Temed, 0.4 mL/mL; and ammonium
persulfate, 0.5 g/L). The acrylamide gradient was
formed by allowing the gradient mixture to fill the
gel casting cassette (Bio Rad Protean Xi Cells; 1.0
mm spacers, 15-well combs) from the bottom by
hydrostatic pressure for 15 to 20 min.
The vertical slab gels were run in the Bio Rad
Protean Xi Cells apparatus. A total volume of 20
μL of plasma sample mixed in a 1:1 volume ratio
with a sample buffer containing 20% sucrose and
0.25% bromophenol blue was loaded onto the gels.
Electrophoresis was performed by using the running
buffer [Tris (180 mmol/L), boric acid (160 mmol/L),
and Na2-EDTA (6 mmol/L pH 8.35)], with cooling
from a thermostatic circulator set at 10 °C for 24 h
at 125 V for a total of 3400 volt-hours, as previously
described (15). Control samples were from 2 wellcharacterized subjects, 1 with large LDL and 1 with
Sd LDL, as previously described (16). The gels were
stained for lipid with Oil Red O (Allied Chemical)
dissolved in 60% ethanol for 24 h at 55-60 °C and
destained in a 5% solution of acetic acid. Gel images
were analyzed with ImageJ software (NIH, USA).
LDL subtype of a patient is determined according
to the relative, or predominant, distribution of
lipoprotein particles.
Statistical analysis
The Mann-Whitney U test was used to compare
means of the groups that did not have a normal
distribution. The Kruskal-Wallis analysis of variation
was used to compare more than 2 groups. Betweengroup differences in gender and smoking habits;
the prevalence of diabetes, hypertension, and
hyperlipidemia; family history; and LDL phenotype
were analyzed by the chi-square test or Fisher’s exact
test.
Results
Patient characteristics
After angiographic evaluation 36 patients were
involved in the stenosis and 20 patients in the nonstenosis group. The male sex, diabetes, and smoking
were significantly more prevalent among the stenosis

cases (P < 0.05). The distribution of risk factors
among 2 groups is summarized in Table 1.
Plasma lipids
Mean serum TG, TC, and LDL levels were similar
between the stenosis and the non-stenosis group,
whereas mean HDL levels were significantly lower in
the stenosis group than in the non-stenosis group (P
< 0.05) (Table 1).
Table 1. Characteristics of stenosis and non-stenosis patients.
Stenosis
(n = 36)

Non-stenosis
(n = 20)

Age

54.4 ± 9.4

53.8 ± 10.7

Sex, male

23 (63.9)*

7 (35)

Hypertension

17 (47.2)

9 (45)

Diabetes mellitus

14 (38.9)*

3 (15)

Hyperlipidemia

26 (72.2)

13 (65)

Smoking

21 (58.3)*

6 (30)

Family history

15 (41.7)

11 (55)

Total cholesterol

215.4 ± 53.7

217.3 ± 41.9

HDL

39.2 ± 9.3*

46.4 ± 10.6

LDL

129.2 ± 45.8

134.4 ± 37.9

Triglyceride

195.9 ± 135.8

157.3 ± 104.5

Lipoproteins (mg/dL)

Values are frequency (%) or mean ± SD;
*P < 0.05.

LDL subtypes
When the gels were evaluated at the end of 24 h
electrophoresis the largest lipid particles remained
near the origin, and smaller particles migrated
farther in accordance with their particle size. LDL
particles were separated over a distance of 25 to 30
mm of the 3% to 7.5% polyacrylamide gel (Figure).
The distribution of LDL subtypes in the stenosis
and non-stenosis groups is summarized in Table 2.
Although Sd LDL positivity was slightly higher in the
stenosis group compared to the non-stenosis group,
the difference between the groups was not significant
(Table 2).
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(P < 0.005). In 14 patients TG levels were greater than
200 mg/dL, and 10 patients had small LDL.

Patient samples
2
3

Gradient PAGE

3%

Large
Medium
Small

7.5%

Figure. Representative gel photograph of 3 patient samples with
each different LDL subtype: small, dense, medium, and
large LDL. Sd LDL particles migrated farthest in the gel
with a gradient of 3%-7.5% polyacrylamide.

Table 2. Distribution of LDL subtypes among stenosis and nonstenosis groups.
Stenosis
(n = 36)

Non-stenosis
(n = 20)

11 (30.5 )

5 (25)

Medium LDL

6 (16.7)

6 (30)

Large LDL

19 (52.8)

9 (45)

Sd LDL

Values are frequency (%).

Association between LDL subtypes and plasma
lipids
Of the 56 patients who underwent coronary
angiography 28 had large LDL, 12 had medium LDL,
and 16 had Sd-LDL. Mean TG, TC, HDL, and LDL
levels for each LDL subtype are shown in Table 3.
Mean TG levels were significantly higher in the SdLDL group than in the medium and large LDL groups

Discussion
In the present study, plasma LDL subtypes
were determined in patients undergoing coronary
angiography to evaluate the positivity of an emerging
risk factor for CAD—Sd LDL—in stenosis and nonstenosis cases. While both groups had a similar
percentage of Sd LDL in this study, mean TG levels
were significantly higher in patients having Sd LDL
subtype compared to patients with medium and large
LDL.
Considering atherosclerosis risk factors, the
stenosis group had 2 times more male patients, more
than 2 times the diabetes patients, and almost 2 times
more smokers compared to the non-stenosis group.
HDL is the only lipid parameter that is different
between the groups; stenosis patients had lower
mean HDL levels.
Although we expected to find higher Sd LDL
positivity in the stenosis group, which also had
a higher diabetes incidence, we observed similar
LDL positivity between groups that also had
similar mean TG levels. While the metabolic origin
of the Sd LDL particle is not totally understood,
hypertriglyceridemia was proposed as a trigger
for its formation (17), and it was shown that LDL
size correlated well with TG levels (18). Serum TG
concentration was reported to be the most important
determinant of the presence of Sd LDL particles in
patients with metabolic syndrome (19).
Previously in the Physician’s Health Study Survey
it was proposed that Sd LDL increased the risk for

Table 3. Mean values of the lipid parameters in each LDL subtype.
Large LDL

Medium LDL

Sd LDL

Triglyceride

143.8 ± 65

121.5 ± 41.1

273.6 ± 174*

Total cholesterol

209.3 ± 53

203.1 ± 31.1

243.9 ± 50.6

HDL

42.4 ± 11

41.5 ± 7.7

37 ± 8.3

LDL

134.1 ± 43

121.3 ± 33.8

135.5 ± 51

Values are mean ± SD;
*P < 0.001.
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coronary artery disease. However, in multivariate
analysis it was found that Sd LDL did not have any
significant effect in coronary heart disease, but TG
levels continued their effect (20). Interestingly, CAD
and LDL size were found to be unrelated in a study
concerning an older population in Finland (21).
Sd LDL positivity was found to be similar between
chronic hemodialysis patients and healthy controls,
and, additionally, hemodialysis patients with or
without coronary artery disease had similar Sd LDL
proportion and size (22).
In the current study Sd LDL positivity was higher
but statistically insignificant in stenosis patients. The
relation between LDL size and incidence of coronary
events during follow-ups had been evaluated
by prospective studies, which reported Sd LDL
positivity before diagnosis of coronary events (20,23).
Therefore, the presence of Sd LDL in non-stenosis
patients may imply a risk for the development of
future stenosis, and these patients should be followed
up carefully with risk reduction and drug therapy.
It is surprising that in this study nearly half of
the patients in the stenosis group had large LDL. In
a previous study LDL size was found to be identical
in patients with cardiovascular disease and controls.
It was concluded that large LDL size might be
an independent predictor of coronary events by
different mechanisms than Sd LDL (24). Large LDL
had reduced affinity for LDL receptor, which clears
LDL from plasma, and has been found capable of
depositing more cholesterol into plaque than Sd LDL
(25). A report from ~5500 asymptomatic individuals

in the Multi-Ethnic Study of Atherosclerosis implied
that higher concentrations of large LDL were
significantly associated with carotid intima media
thickness, which is a direct and well-validated
measure of subclinical atherosclerosis, and concluded
that both small and large LDL were “atherogenic” to a
similar extent (26)
Although it has been investigated as a marker of
atherogenic dyslipidemia and coronary risk factor
(10), the ability of Sd LDL to cause heart disease
independent of other factors (such as diabetes and
hypertriglyceridemia) has not been fully established.
Perhaps as a result of this, it has not been recommended
as a routine test in daily clinical practice, yet (27).
However, studying lipoprotein subtypes is important
for advancing research, developing potentially novel
therapies, and understanding the pathophysiology of
atherothrombotic diseases (28). In the current study
Sd LDL positivity was relatively higher in coronary
stenosis patients; however, it was not statistically
significant. Large prospective cohort studies and
intervention studies may help to determine whether
Sd LDL should be used as a routine test in the
diagnosis and follow up of atherosclerosis and CAD.
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